Suppr超能文献

与阴道栓剂相比,米索前列醇片用于引产时女性的体验。

Women's experiences of induction of labour with misoprostol tablets compared with vaginal insert.

机构信息

Department of Obstetrics and Gynaecology, Copenhagen University Hospital - Holbaek Hospital.

Department of Gynaecology and Obstetrics, Copenhagen University Hospital - Amager and Hvidovre Hospital.

出版信息

Dan Med J. 2023 Jan 24;70(2):A04220232.

Abstract

INTRODUCTION

The aim of this study was to compare nulliparous women's experiences with induction of labour using two different regimens of misoprostol.

METHODS

We adapted a validated questionnaire regarding experience with induced labour. In two different hospitals, 123 women undergoing medical induction of labour completed a questionnaire after delivery. An independent-samples T-test was used for comparison of parametric continuous variables and Pearson's χ2 test was used for categorical data. The two groups differed regarding BMI and pregnancy complications. No adjusted estimates were calculated.

RESULTS

Women induced with oral misoprostol experienced more painful induction of labour (p = 0.019) and described feeling that their length of stay at hospital was excessive (p = 0.028). Overall, the experience of giving birth after induction of labour was reported as "good" among 87.8% of women induced with oral misoprostol compared with 72.7% of the women induced with a slow-release misoprostol vaginal insert (p = 0.039).

CONCLUSION

In two departments characterized by several differences, including whether vaginal or oral misoprostol was used, induction with oral misoprostol in an out-patient setting was associated with a better experience of labour than induction with a slow-release misoprostol vaginal insert.

FUNDING

Region Zealand Health Scientific Research Foundation supported the study financially.

TRIAL REGISTRATION

The study was registered with clinicaltrials.gov ID: NCT02693587 on 26 February 2016 and with EudraCT number 2020-000366-42 on 23 January 2020 (retrospectively registered).

摘要

简介

本研究旨在比较两种不同米索前列醇方案用于引产时初产妇的体验。

方法

我们改编了一份关于引产体验的经过验证的问卷。在两家不同的医院,123 名接受药物引产的初产妇在分娩后完成了问卷。采用独立样本 T 检验比较参数连续变量,采用 Pearson χ2 检验比较分类数据。两组在 BMI 和妊娠并发症方面存在差异。未计算调整后的估计值。

结果

口服米索前列醇引产的产妇经历了更痛苦的引产过程(p=0.019),并认为她们在医院的逗留时间过长(p=0.028)。总体而言,87.8%口服米索前列醇引产的产妇报告分娩后体验“良好”,而 72.7%阴道放置缓慢释放米索前列醇的产妇报告分娩后体验“良好”(p=0.039)。

结论

在两个具有多个差异的科室中,包括是否使用阴道或口服米索前列醇,门诊口服米索前列醇引产与阴道缓慢释放米索前列醇引产相比,产妇的分娩体验更好。

基金

丹麦西兰大区健康科学研究基金会为该研究提供资金支持。

试验注册

该研究于 2016 年 2 月 26 日在 clinicaltrials.gov 注册号为 NCT02693587,并于 2020 年 1 月 23 日在 EudraCT 注册号为 2020-000366-42(追溯注册)。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验